The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) U Halbreich, J Borenstein, T Pearlstein, LS Kahn Psychoneuroendocrinology 28, 1-23, 2003 | 890 | 2003 |
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects U Halbreich, BJ Kinon, JA Gilmore, LS Kahn Psychoneuroendocrinology 28, 53-67, 2003 | 342 | 2003 |
Role of estrogen in the aetiology and treatment of mood disorders U Halbreich, LS Kahn CNS drugs 15, 797-817, 2001 | 329 | 2001 |
Bipolar disorder and metabolic syndrome: an international perspective RS McIntyre, M Danilewitz, SS Liauw, DE Kemp, HTT Nguyen, LS Kahn, ... Journal of affective disorders 126 (3), 366-387, 2010 | 254 | 2010 |
Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? U Halbreich, LS Kahn Journal of affective disorders 102 (1-3), 245-258, 2007 | 175 | 2007 |
Hormonal aspects of schizophrenias: an overview U Halbreich, LS Kahn Psychoneuroendocrinology 28, 1-16, 2003 | 167 | 2003 |
Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap RS McIntyre, NL Rasgon, DE Kemp, HT Nguyen, CWY Law, VH Taylor, ... Current Diabetes Reports 9 (1), 51-59, 2009 | 154 | 2009 |
Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects U Halbreich, LS Kahn Journal of Psychiatric Practice® 9 (5), 344-353, 2003 | 109 | 2003 |
Diabetes self-management in a low-income population: impacts of social support and relationships with the health care system BM Vest, LS Kahn, A Danzo, L Tumiel-Berhalter, RC Schuster, R Karl, ... Chronic illness 9 (2), 145-155, 2013 | 97 | 2013 |
Adolescent substance use and abuse: recognition and management KS Griswold, H Aronoff, JB Kernan, LS Kahn American family physician 77 (3), 331-336, 2008 | 81 | 2008 |
Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study CH Fox, A Swanson, LS Kahn, K Glaser, BM Murray The Journal of the American Board of Family Medicine 21 (6), 522-530, 2008 | 69 | 2008 |
An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes JS Cramer, RF Sibley, DP Bartlett, LS Kahn, L Loffredo The Diabetes Educator 33 (3), 503-508, 2007 | 62 | 2007 |
Oral contraceptives and mood LS Kahn, U Halbreich Expert opinion on pharmacotherapy 2 (9), 1367-1382, 2001 | 59 | 2001 |
Chronic kidney disease (CKD) treatment burden among low-income primary care patients LS Kahn, BM Vest, N Madurai, R Singh, TRM York, CW Cipparone, ... Chronic illness 11 (3), 171-183, 2015 | 57 | 2015 |
Chronic kidney disease guideline implementation in primary care: a qualitative report from the TRANSLATE CKD study BM Vest, TRM York, J Sand, CH Fox, LS Kahn The Journal of the American Board of Family Medicine 28 (5), 624-631, 2015 | 55 | 2015 |
Nursing recruitment and retention in New York State: a qualitative workforce needs assessment CS Brewer, LE Zayas, LS Kahn, MJ Sienkiewicz Policy, Politics, & Nursing Practice 7 (1), 54-63, 2006 | 54 | 2006 |
Selective oestrogen receptor modulators-current and future brain and behaviour applications U Halbreich, LS Kahn Expert Opinion on Pharmacotherapy 1 (7), 1385-1398, 2000 | 54 | 2000 |
Identifying barriers and facilitating factors to improve screening mammography rates in women diagnosed with mental illness and substance use disorders LS Kahn, CH Fox, J Krause-Kelly, DE Berdine, RB Cadzow Women & health 42 (3), 111-126, 2006 | 41 | 2006 |
Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices MF Mitwally, LS Kahn, U Halbreich Expert opinion on pharmacotherapy 3 (11), 1577-1590, 2002 | 38 | 2002 |
Inaccuracy of ICD-9 codes for chronic kidney disease: a study from two practice-based research networks (PBRNs) CW Cipparone, M Withiam-Leitch, KS Kimminau, CH Fox, R Singh, ... The Journal of the American Board of Family Medicine 28 (5), 678-682, 2015 | 36 | 2015 |